Modulating tumor immunity by metronomic dosing of oxaliplatin incorporated in multiple oral nanoemulsion

Journal of Controlled Release ◽

10.1016/j.jconrel.2020.03.012 ◽

2020 ◽

Vol 322 ◽

pp. 13-30 ◽

Author(s):

Jeong Uk Choi ◽

Ruby Maharjan ◽

Rudra Pangeni ◽

Saurav Kumar Jha ◽

Na Kyeong Lee ◽

...

Keyword(s):

Tumor Immunity ◽

Metronomic Dosing

Download Full-text

Review for "Transcutaneous immunization with CD40 ligation boosts cytotoxic T lymphocyte mediated anti‐tumor immunity independent of CD4 helper cells in mice"

10.1002/eji.201848039/v1/review1 ◽

2019 ◽

Keyword(s):

Tumor Immunity ◽

T Lymphocyte ◽

Cytotoxic T Lymphocyte ◽

Cd40 Ligation ◽

Helper Cells ◽

Transcutaneous Immunization

Download Full-text

Endoplasmic Reticulum and Its Role in Tumor Immunity

10.3389/978-2-88919-786-6 ◽

2016 ◽

Keyword(s):

Endoplasmic Reticulum ◽

Download Full-text

Escape Mechanisms in Tumor Immunity: An Update

Journal of Environmental Pathology Toxicology and Oncology ◽

10.1615/jenvironpatholtoxicoloncol.v21.i4.10 ◽

2002 ◽

Vol 21 (4) ◽

pp. 54 ◽

Author(s):

Ludmila Muller ◽

Rolf Kiessling ◽

Robert C. Rees ◽

Graham Pawelec

Keyword(s):

Download Full-text

Chimeric antibody receptors CARs Driving T-cell specificity to enhance anti-tumor immunity

Frontiers in Bioscience ◽

10.2741/s282 ◽

2012 ◽

Vol S4 (2) ◽

pp. 520-531 ◽

Author(s):

Partow Kebriaei

Keyword(s):

T Cell ◽

Tumor Immunity ◽

Chimeric Antibody ◽

Cell Specificity

Download Full-text

Faculty Opinions recommendation of Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1007307.90209 ◽

2002 ◽

Author(s):

Glenn Dranoff

Keyword(s):

Dendritic Cells ◽

Tumor Immunity ◽

Fcgamma Receptors

Download Full-text

Faculty Opinions recommendation of IL-21 enhances and sustains CD8+ T cell responses to achieve durable tumor immunity: comparative evaluation of IL-2, IL-15, and IL-21.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1020664.236442 ◽

2004 ◽

Author(s):

Arthur Hurwitz

Keyword(s):

T Cell ◽

Tumor Immunity ◽

Comparative Evaluation ◽

T Cell Responses ◽

Download Full-text

Faculty Opinions recommendation of Antigen localization controls T cell-mediated tumor immunity.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.12605959.13845062 ◽

2011 ◽

Author(s):

Howard Young

Keyword(s):

T Cell ◽

Tumor Immunity ◽

Antigen Localization

Download Full-text

Faculty Opinions recommendation of Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717952904.793460272 ◽

2012 ◽

Author(s):

David Kranz

Keyword(s):

T Cells ◽

Tumor Immunity ◽

Download Full-text

Faculty Opinions recommendation of Mast cells impair the development of protective anti-tumor immunity.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.720882164.793502140 ◽

2014 ◽

Author(s):

Olivier Hermine ◽

Ivan Cruz Moura ◽

Thiago Maciel

Keyword(s):

Download Full-text

Faculty Opinions recommendation of Combining BRAF inhibitor and anti PD-L1 antibody dramatically improves tumor regression and anti tumor immunity in an immunocompetent murine model of anaplastic thyroid cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726191113.793541393 ◽

2018 ◽

Author(s):

Maria Cabanillas

Keyword(s):

Thyroid Cancer ◽

Tumor Immunity ◽

Murine Model ◽

Tumor Regression ◽

Braf Inhibitor ◽

Anaplastic Thyroid Cancer

Download Full-text